- Todos > Medicine Access and Rational Use > Controlled Medicines
- Todos > Quality and Safety: Medicines > Regulatory Support
- Palabras clave > Access to Opioid Medications in Europe (ATOME)
- Palabras clave > controlled medications
- Palabras clave > controlled substances
- Palabras clave > legal framework
- Palabras clave > legislation
- Palabras clave > opioids
- Palabras clave > pain treatment
- Palabras clave > palliative care
- Palabras clave > regulation
(2012; 6 pages)
The Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology at Utrecht University published the results of the quick scan of legislations undertaken as part of the ATOME project. WHO is a partner in this project.
The main objective of ATOME is to improve the access to opioid medication in Europe. This overall aim will be implemented through several aims, including a legislation review of nine Eastern European countries to identify barriers to access and make recommendations for improvement. In order to select the nine countries with the most impeding legislation all 12 ATOME target countries (Bulgaria, Cyprus, Estonia, Greece, Hungary, Latvia, Lithuania, Poland, Serbia, Slovakia, Slovenia and Turkey) have been approached for a scan of their legislation. This report presents the methods, results and the conclusions (selection of nine countries that will be further reviewed) of the quick scan of national legislation of the ATOME target countries...